Literature DB >> 16498380

Mumps epidemic--United kingdom, 2004-2005.

.   

Abstract

During 2004-2005, the United Kingdom (UK) experienced a nationwide epidemic of mumps, which peaked during 2005 when 56,390 notified cases were reported in England and Wales. The majority of confirmed cases during 2004-2005 were in persons aged 15-24 years, most of whom had not been eligible for routine mumps vaccination. Mumps usually is a self-limited viral disease that appears as parotitis. However, mumps also can lead to serious complications such as encephalitis or pancreatitis. This report summarizes the epidemiology of the 2004-2005 mumps epidemic in England and Wales.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16498380

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  24 in total

1.  Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease.

Authors:  Kh Muhsen; Y Aboudy; E Mendelson; M S Green; D Cohen
Journal:  Epidemiol Infect       Date:  2007-07-03       Impact factor: 2.451

2.  Is mumps making a comeback?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

3.  Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus.

Authors:  Pei Xu; Zhuo Li; Dengyun Sun; Yuan Lin; Jianguo Wu; Paul A Rota; Biao He
Journal:  Virology       Date:  2011-06-14       Impact factor: 3.616

4.  Mumps: resurgence of a vanquished virus.

Authors:  Scott D Smith; Ian Gemmill
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

5.  An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada.

Authors:  Shelley L Deeks; Gillian H Lim; Mary Anne Simpson; Louise Gagné; Jonathan Gubbay; Erik Kristjanson; Cecilia Fung; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-05-16       Impact factor: 8.262

6.  The relationship between meteorological factors and mumps incidence in Guangzhou, China, 2005-2012:.

Authors:  Qiongying Yang; Zhicong Yang; Haiyuan Ding; Xiao Zhang; Zhiqiang Dong; Wensui Hu; Xiangyi Liu; Ming Wang; Guifang Hu; Chuanxi Fu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.

Authors:  Ken Lemon; Bertus K Rima; Stephen McQuaid; Ingrid V Allen; W Paul Duprex
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

9.  Characterization of large mumps outbreak among vaccinated Palestinian refugees.

Authors:  Musa Y Hindiyeh; Yair Aboudy; Mahmoud Wohoush; Lester M Shulman; Daniela Ram; Tal Levin; Tamar Frank; Flavia Riccardo; Mohamad Khalili; Elias-Shlash Sawalha; Maysoun Obeidi; Guido Sabatinelli; Zehava Grossman; Ella Mendelson
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

10.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.